‘All hands on deck’ needed to address U.S. pain and addiction innovation
The number of new pain drugs in the development pipeline has slowed to a trickle and investment in addiction drugs is low, challenges addressed […]
‘All hands on deck’ needed to address U.S. pain and addiction innovation Read More »